Aurobindo Pharma clarifies, reports of Zentiva buyout ‘premature’, no binding agreement yet
Aurobindo Pharma, a leading player in the active pharmaceutical ingredient and generic market, has issued a statement clarifying that reports of buying out Prague-based generic drugmaker Zentiva are ‘premature’, and…







